| ORASURE TECHNOLOGIES |
| USA |
| Gesundheit |
| US68554V1089 / 881351 |
| EP3 (Frankfurt) / OSUR (NASDAQ) |
| FRA:EP3, ETR:EP3, EP3:GR, NASDAQ:OSUR |
| - |
| https://orasure.com/ |
|
Orasure Technologies Inc. is a biotechnology company primarily focused on developing point-of-care diagnostic testing and specimen collection devices. Known for its innovation in oral fluid diagnostic..
>Volltext.. |
| 187.47 Mio. EUR |
| 53.09 Mio. EUR |
| 99.66 Mio. EUR |
| -52.23 Mio. EUR |
| -59.55 Mio. EUR |
| -0.81 EUR |
| 35.45 Mio. EUR |
| 172.66 Mio. EUR |
| -42.48 Mio. EUR |
| 5.01 |
| -45.44% |
| -210.67% |
| - |
| - |
| - |
| - |
| ORASURE |
| 18.03.26 |